Fredun Pharmaceuticals Ltd — Results, 31-05-2025: Result

Fredun Pharmaceuticals has announced a board meeting on which it approved the financial results for the quarter and half-year. The company reported standalone revenue from operations of ₹451.71 Cr, up from ₹346.58 Cr, and net profit rose to ₹20.81 Cr from ₹15.62 Cr YoY. Earnings per share increased to ₹44.83 from ₹33.66. The Board approved a final dividend of 7% per equity share, subject to shareholder approval. On the consolidated front, revenue stood at ₹451.71 Cr with net profit at ₹19.74 Cr. The company expanded by incorporating Fredun Retail Pvt Ltd and acquiring One Pet Stop Pvt Ltd as a step-down subsidiary. Auditors issued an unmodified opinion but noted delays in transferring unclaimed dividends and shares to the Investor Education and Protection Fund.